{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:35:22Z","timestamp":1777401322525,"version":"3.51.4"},"reference-count":191,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.survophthal.2013.01.003","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T05:15:36Z","timestamp":1381209336000},"page":"97-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Local chemotherapeutic agents for the treatment of ocular malignancies"],"prefix":"10.1016","volume":"59","author":[{"given":"Bruno F.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Nikolitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Novais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Odashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia P.","family":"Odashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubens N.","family":"Belfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Miguel N.","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2013.01.003_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003495-200666030-00005","article-title":"Mitomycin: clinical applications in ophthalmic practice","volume":"66","author":"Abraham","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.survophthal.2013.01.003_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003495-200767020-00005","article-title":"The clinical applications of fluorouracil in ophthalmic practice","volume":"67","author":"Abraham","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.survophthal.2013.01.003_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/bjo.2009.174268","article-title":"Super selective ophthalmic artery delivery of chemotherapy for intraocular retinoblastoma: \u2018chemosurgery\u2019 the first Stallard lecture","volume":"94","author":"Abramson","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archopht.123.1.128-b","article-title":"Periocular chemotherapy for retinoblastoma: success with problems? [Comment]","volume":"123","author":"Abramson","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A\u00a0phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ophtha.2009.12.030","article-title":"Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery)","volume":"117","author":"Abramson","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib7","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0161-6420(99)90406-2","article-title":"A\u00a0phase I\/II study of subconjunctival carboplatin for intraocular retinoblastoma","volume":"106","author":"Abramson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","article-title":"Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results","volume":"96","author":"Abramson","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib9","unstructured":"AHFS: Carboplatin IV: AHFS Detailed Monograph: AHFS Drug Information. Bethesda, MD, American Society of Health-System Pharmacists, Inc., January 2009"},{"key":"10.1016\/j.survophthal.2013.01.003_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/10428190400019826","article-title":"Long-term survival of patients with resistant lymphoma treated with tandem stem cell transplant","volume":"46","author":"Ahmed","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.survophthal.2013.01.003_bib11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/bjo.2006.107482","article-title":"Ocular surface toxicity associated with topical interferon alpha-2b","volume":"91","author":"Aldave","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ajo.2008.04.008","article-title":"Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes","volume":"146","author":"Alvarado","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10792-008-9225-3","article-title":"Primary acquired melanosis with atypia treated with mitomycin C","volume":"29","author":"Anandajeya","year":"2009","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/IOP.0b013e3181ac4c39","article-title":"Long-term results of topical mitomycin C 0. 02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia","volume":"25","author":"Ballalai","year":"2009","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2013.01.003_bib15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","article-title":"The interferons. Mechanisms of action and clinical applications","volume":"266","author":"Baron","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.survophthal.2013.01.003_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00003226-200310000-00015","article-title":"Ocular surface squamous neoplasia: a review","volume":"22","author":"Basti","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3747\/co.v16i5.374","article-title":"Response to 5-fluorouracil in metastatic extramammary Paget disease of the scrotum presenting as pancytopenia and back pain","volume":"16","author":"Beleznay","year":"2009","journal-title":"Curr Oncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0305-7372(77)80007-8","article-title":"Methotrexate: clinical pharmacology, current status and therapeutic guidelines","volume":"4","author":"Bleyer","year":"1977","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.survophthal.2013.01.003_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-9394(82)90239-2","article-title":"Fluorouracil for the treatment of massive periretinal proliferation","volume":"94","author":"Blumenkranz","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib20","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.ophtha.2004.01.034","article-title":"Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b","volume":"111","author":"Boehm","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib21","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1167\/iovs.08-1751","article-title":"Targeting hypoxia, a novel treatment for advanced retinoblastoma","volume":"49","author":"Boutrid","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1442-9071.2006.01356.x","article-title":"Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment","volume":"34","author":"Chalasani","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/107327480401100502","article-title":"Intraocular lymphoma: update on diagnosis and management","volume":"11","author":"Chan","year":"2004","journal-title":"Cancer Control"},{"key":"10.1016\/j.survophthal.2013.01.003_bib24","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jcrs.2003.12.044","article-title":"Early corneal edema following topical application of mitomycin-C","volume":"30","author":"Chang","year":"2004","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2013.01.003_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bjo.88.1.17","article-title":"Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia","volume":"88","author":"Chen","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01.ico.0000126320.36014.d1","article-title":"Adjunctive treatment with interferon alpha-2b may decrease the risk of papilloma-associated conjunctival intraepithelial neoplasm recurrence","volume":"23","author":"Chen","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1442-9071.2007.01640.x","article-title":"Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment","volume":"35","author":"Chen","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1442-6404.2002.00497.x","article-title":"Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia","volume":"30","author":"Daniell","year":"2002","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2011.05.034","article-title":"Keratocyte density 3 months, 15 months, and 3 years after corneal surface ablation with mitomycin C","volume":"153","author":"de Benito-Llopis","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00166683","article-title":"Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid","volume":"64","author":"de Keizer","year":"1986","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjo.83.4.448","article-title":"Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma","volume":"83","author":"de Smet","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib32","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/archopht.1991.01080120013002","article-title":"Potential toxicity of mitomycin C","volume":"109","author":"Derick","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib33","first-page":"206","article-title":"Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye","volume":"106","author":"Derment","year":"2008","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2013.01.003_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00003226-200401000-00016","article-title":"A\u00a0case of conjunctiva\u2013cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles","volume":"23","author":"Di Pascuale","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib35","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1167\/iovs.10-5392","article-title":"Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications","volume":"51","author":"Edelhauser","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/02713680701528674","article-title":"Methotrexate delivery to the eye using transscleral hydrogel iontophoresis","volume":"32","author":"Eljarrat-Binstock","year":"2007","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2013.01.003_bib37","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1167\/iovs.05-0495","article-title":"Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance","volume":"47","author":"Enriquez de Salamanca","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1755-3768.1964.tb01723.x","article-title":"Trials of intravitreal injections of chemotherapeutic agents in rabbits","volume":"42","author":"Ericson","year":"1964","journal-title":"Acta Opthalmologica"},{"key":"10.1016\/j.survophthal.2013.01.003_bib39","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/bjo.2004.063339","article-title":"Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b","volume":"89","author":"Esquenazi","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bjo.82.5.476","article-title":"Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia","volume":"82","author":"Finger","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bjo.77.11.751","article-title":"Topical chemotherapy for conjunctival melanoma","volume":"77","author":"Finger","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajo.2007.08.027","article-title":"Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex","volume":"145","author":"Finger","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib43","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archopht.1997.01100160322009","article-title":"Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma","volume":"115","author":"Fishburne","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib44","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/10428190701824569","article-title":"Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells","volume":"49","author":"Fotoohi","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.survophthal.2013.01.003_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/00001622-199212000-00012","article-title":"Cisplatin and platinum analogues: recent advances","volume":"4","author":"Fram","year":"1992","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bjo.2007.127928","article-title":"Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience","volume":"92","author":"Frenkel","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib47","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0161-6420(01)00967-8","article-title":"Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma","volume":"109","author":"Frucht-Pery","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib48","first-page":"51","article-title":"[A case of conjunctival malignant melanoma treated with subconjunctival injection of interferon beta\u2014efficacy and side effects]","volume":"110","author":"Fujioka","year":"2006","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.survophthal.2013.01.003_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/10611869708995844","article-title":"Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC\u2013gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice","volume":"4","author":"Fujita","year":"1997","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.survophthal.2013.01.003_bib50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/cr030117g","article-title":"Antitumor antibiotics: bleomycin, enediynes, and mitomycin","volume":"105","author":"Galm","year":"2005","journal-title":"Chem Rev"},{"key":"10.1016\/j.survophthal.2013.01.003_bib51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bjo.2008.153197","article-title":"Topical interferon alpha 2b eye drops for treatment of ocular surface squamous neoplasia: a dose comparison study","volume":"94","author":"Galor","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3928\/15428877-20070701-02","article-title":"Combined 5-fluorouracil, low-molecular-weight heparin, and silicone oil in the management of complicated retinal detachment with proliferative vitreoretinopathy grade C","volume":"38","author":"Garcia","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.survophthal.2013.01.003_bib53","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.survophthal.2013.01.003_bib54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0002-9394(99)80165-2","article-title":"Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia","volume":"125","author":"Gebhardt","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/pbc.22347","article-title":"Thiotepa\/topotecan\/carboplatin with autologous stem cell rescue in recurrent\/refractory\/poor prognosis pediatric malignancies of the central nervous system","volume":"54","author":"Gilheeney","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.survophthal.2013.01.003_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.1999.17.1.409","article-title":"Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin","volume":"17","author":"Go","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib57","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib58","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.ophtha.2007.03.040","article-title":"Intraocular lymphoma","volume":"114","author":"Goldberg","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib59","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ijgc-00009577-200211000-00004","article-title":"Thiotepa in combination with cisplatin for primary epithelial ovarian cancer: a phase II study","volume":"12","author":"Gordinier","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.survophthal.2013.01.003_bib60","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1167\/iovs.03-0959","article-title":"Ophthalmic drug delivery through contact lenses","volume":"45","author":"Gulsen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib61","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bjo.2009.168294","article-title":"Treatment of ocular surface squamous neoplasia with Mitomycin C","volume":"94","author":"Gupta","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib62","first-page":"864","article-title":"Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments","volume":"9","author":"Han","year":"2010","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib63","first-page":"1892","article-title":"Local carboplatin therapy in transgenic murine retinoblastoma","volume":"37","author":"Harbour","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib64","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1167\/iovs.06-0365","article-title":"Iontophoretic delivery of carboplatin in a murine model of retinoblastoma","volume":"47","author":"Hayden","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib65","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1167\/iovs.04-0228","article-title":"Pharmacokinetics of systemic versus focal carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma","volume":"45","author":"Hayden","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib66","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archopht.118.11.1549","article-title":"Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule","volume":"118","author":"Hayden","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib67","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.1999.17.4.1326c","article-title":"Intraocular methotrexate level after high-dose intravenous infusion. [comment]","volume":"17","author":"Henson","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00417-009-1189-0","article-title":"Interferon alpha for the treatment of melanocytic conjunctival lesions","volume":"248","author":"Herold","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib69","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ophtha.2006.09.026","article-title":"Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution","volume":"114","author":"Hirst","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib70","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ajo.2006.05.058","article-title":"Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia","volume":"142","author":"Holcombe","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib71","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bjo.2008.154427","article-title":"Emerging options in the management of advanced intraocular retinoblastoma. [comment]","volume":"93","author":"Honavar","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib72","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0002-9394(99)80252-9","article-title":"Interferon treatment for corneolimbal squamous dysplasia","volume":"125","author":"Hu","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib73","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpba.2006.06.032","article-title":"Determination of doxorubicin in rabbit ocular tissues and pharmacokinetics after intravitreal injection of a single dose of doxorubicin-loaded poly-\u03b2-hydroxybutyrate microspheres","volume":"43","author":"Hu","year":"2007","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.survophthal.2013.01.003_bib74","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/01.ico.0000240088.38631.46","article-title":"Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva\u2013cornea intraepithelial neoplasia","volume":"25","author":"Huerva","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jop.2006.0114","article-title":"Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva\u2013cornea intraepithelial neoplasia","volume":"23","author":"Huerva","year":"2007","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2013.01.003_bib76","first-page":"2009","article-title":"Efficacy of low-dose topical mitomycin C treatment for primary acquired melanosis","author":"Hung","year":"2009","journal-title":"BMJ Case Reports 2009"},{"key":"10.1016\/j.survophthal.2013.01.003_bib77","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0161-6420(92)31781-6","article-title":"Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts","volume":"99","author":"Jampel","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib78","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1167\/iovs.07-0708","article-title":"Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model","volume":"48","author":"Jockovich","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib79","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jjco\/hyg113","article-title":"Eye-preservation treatment of retinoblastoma with vitreous seeding","volume":"33","author":"Kaneko","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib80","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1076\/ceyr.22.3.174.5513","article-title":"Mechanism of growth inhibitory effect of Mitomycin-C on cultured human retinal pigment epithelial cells: apoptosis and cell cycle arrest","volume":"22","author":"Kang","year":"2001","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2013.01.003_bib81","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.ophtha.2010.03.052","article-title":"Subconjunctival\/perilesional recombinant interferon alpha2b for ocular surface squamous neoplasia\u2014a 10-year review","volume":"117","author":"Karp","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib82","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0161-6420(01)00577-2","article-title":"Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b","volume":"108","author":"Karp","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bjo.86.1.31","article-title":"Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias","volume":"86","author":"Kemp","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib84","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/archopht.1992.01080200130040","article-title":"Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts","volume":"110","author":"Khaw","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib85","doi-asserted-by":"crossref","unstructured":"Kim E, Durairaj C, Kadam R, et\u00a0al. Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation. Pharm Res. 2009;26:1155\u20131161","DOI":"10.1007\/s11095-009-9835-0"},{"key":"10.1016\/j.survophthal.2013.01.003_bib86","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3341\/kjo.2009.23.3.210","article-title":"A\u00a0case of primary intraocular lymphoma treated by intravitreal methotrexate","volume":"23","author":"Kim","year":"2009","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib87","first-page":"404","article-title":"Severe pseudo-preseptal cellulitis following sub-Tenon's carboplatin injection for intraocular retinoblastoma","volume":"11","author":"Kiratli","year":"2007","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.survophthal.2013.01.003_bib88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0021-5155(01)00494-4","article-title":"Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b","volume":"46","author":"Kobayashi","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib89","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00417-004-1080-y","article-title":"Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience","volume":"243","author":"Kurli","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib90","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0039-6257(05)80054-2","article-title":"Ocular surface squamous neoplasia","volume":"39","author":"Lee","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib91","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajo.2009.04.004","article-title":"Frontiers in the management of retinoblastoma","volume":"148","author":"Lin","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib92","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1081\/CNV-100106152","article-title":"What is the \u201cbest\u201d platinum: cisplatin, carboplatin, or oxaliplatin?","volume":"19","author":"Lokich","year":"2001","journal-title":"Cancer Invest"},{"key":"10.1016\/j.survophthal.2013.01.003_bib93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1008215213739","article-title":"Carboplatin versus cisplatin in solid tumors: an analysis of the literature","volume":"9","author":"Lokich","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib94","first-page":"166","article-title":"Antimetabolite and releasable suture augmented filtration surgery in refractory pediatric glaucomas","volume":"12","author":"Low","year":"2008","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.survophthal.2013.01.003_bib95","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/IOP.0b013e3181b9e73e","article-title":"Treatment of recurrent eyelid margin verruca vulgaris with mitomycin C","volume":"26","author":"Ma'luf","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2013.01.003_bib96","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/jop.2007.0110","article-title":"Fibrin sealant for retinoblastoma: where are we?","volume":"24","author":"Martin","year":"2008","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2013.01.003_bib97","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archopht.1994.01090210029007","article-title":"Regression of limbal epithelial dysplasia with topical interferon","volume":"112","author":"Maskin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1005980206723","article-title":"Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma\u2014a report of the Children's Cancer Group","volume":"37","author":"Mason","year":"1998","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib99","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.annder.2009.04.011","article-title":"[Multiple Bowen disease of the lower limbs in elderly women: a rare clinical subset involving therapeutic difficulties]","volume":"136","author":"Maury","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/bjo.84.3.268","article-title":"Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil","volume":"84","author":"Midena","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib101","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/archopht.1997.01100160770023","article-title":"Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil","volume":"115","author":"Midena","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib102","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archopht.121.8.1120","article-title":"Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma [see comment]","volume":"121","author":"Mulvihill","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib103","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib104","first-page":"2516","article-title":"In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line","volume":"38","author":"Murray","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib105","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archopht.1997.01100160456013","article-title":"Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma","volume":"115","author":"Murray","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib106","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archopht.1996.01100140585010","article-title":"Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma","volume":"114","author":"Murray","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib107","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/tx00025a016","article-title":"Alkylation of DNA with aziridine produced during the hydrolysis of N, N', N'-triethylenethiophosphoramide","volume":"5","author":"Musser","year":"1992","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib108","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1517\/13543784.16.9.1467","article-title":"Melphalan: old and new uses of a still master drug for multiple myeloma","volume":"16","author":"Musto","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.survophthal.2013.01.003_bib109","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.12.018","article-title":"Polymeric nanoparticulate system: a potential approach for ocular drug delivery","volume":"136","author":"Nagarwal","year":"2009","journal-title":"J\u00a0Controlled Release"},{"key":"10.1016\/j.survophthal.2013.01.003_bib110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1166\/jbn.2008.004","article-title":"L.\u00a0Nanotechnology in the treatment and detection of intraocular cancers","volume":"4","author":"Nair","year":"2008","journal-title":"J\u00a0Biomed Nanotechnol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib111","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1442-9071.2006.01226.x","article-title":"Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C","volume":"34","author":"Nemet","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib112","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3928\/1081-597X-20060601-08","article-title":"Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits","volume":"22","author":"Netto","year":"2006","journal-title":"J\u00a0Refract Surg"},{"key":"10.1016\/j.survophthal.2013.01.003_bib113","first-page":"96","article-title":"[A comparative study of thiotepa and mitomycin C in the treatment of pterygium. Preliminary results]","volume":"21","author":"Ngoy","year":"1998","journal-title":"J\u00a0Fr Ophtalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib114","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archopht.1990.01070100101043","article-title":"A\u00a0transgenic mouse model for trilateral retinoblastoma","volume":"108","author":"O'Brien","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib115","first-page":"3681","article-title":"Effects of single exposures to antiproliferative agents on ocular fibroblast-mediated collagen contraction","volume":"35","author":"Occleston","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2013.01.003_bib116","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10384-008-0636-5","article-title":"Clinicopathological investigation of a retinoblastoma eye enucleated after vitreous surgery with melphalan perfusion","volume":"53","author":"Ohshima","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib117","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0014-4835(91)90116-V","article-title":"Effects of 5\u2013fluorouracil on proliferating fibroblasts in vivo","volume":"53","author":"Ophir","year":"1991","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2013.01.003_bib118","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PGP.0b013e3181b6a7d7","article-title":"Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapy","volume":"29","author":"Paczos","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib119","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajo.2007.12.004","article-title":"Effect of topical mitomycin C on corneal endothelium","volume":"145","author":"Panda","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00006982-200410000-00015","article-title":"Retinal function after subconjunctival injection of carboplatin in fibrin sealant","volume":"24","author":"Pardue","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2013.01.003_bib121","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1021\/tx9002758","article-title":"Reductive activation of mitomycin C by thiols: kinetics, mechanism, and biological implications","volume":"22","author":"Paz","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib122","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ajo.2004.08.065","article-title":"The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C","volume":"139","author":"Pe'er","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib123","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3171\/2011.1.JNS10466","article-title":"Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors","volume":"114","author":"Peterson","year":"2011","journal-title":"Journal of neurosurgery"},{"key":"10.1016\/j.survophthal.2013.01.003_bib124","doi-asserted-by":"crossref","unstructured":"Phillips RM, Bibby MC, Double JA. Experimental correlations of in vitro drug sensitivity with in vivo responses to thiotepa in a panel of murine colon tumours. 1988;21:168\u2013172","DOI":"10.1007\/BF00257366"},{"key":"10.1016\/j.survophthal.2013.01.003_bib125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00003226-200103000-00011","article-title":"Halting pterygium recurrence by postoperative 5\u2013fluorouracil","volume":"20","author":"Pikkel","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08820530500351694","article-title":"Topical medical therapies for ocular surface tumors","volume":"21","author":"Poothullil","year":"2006","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib127","first-page":"984","article-title":"Effect of thio TEPA on the synthesis of protein and nucleic acids in tumor-bearing mice","volume":"21","author":"Pradhan","year":"1961","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2013.01.003_bib128","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jcrs.2006.05.014","article-title":"Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy","volume":"32","author":"Rajan","year":"2006","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2013.01.003_bib129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00003226-200303000-00006","article-title":"Topical mitomycin C in the treatment of pigmented conjunctival lesions","volume":"22","author":"Rodriguez-Ares","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib130","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1542\/peds.2008-0518","article-title":"Retinoblastoma: one world, one vision","volume":"122","author":"Rodriguez-Galindo","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.survophthal.2013.01.003_bib131","first-page":"119","article-title":"Treatment of ocular leukemia with local chemotherapy","volume":"69","author":"Rootman","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.survophthal.2013.01.003_bib132","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1442-9071.2009.02048.x","article-title":"Mitomycin-C as adjuvant therapy in the treatment of sebaceous gland carcinoma in high-risk locations","volume":"37","author":"Rudkin","year":"2009","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib133","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.3129\/i09-125","article-title":"Topical mitomycin following cryotherapy for treatment of recurrent ocular surface melanoma","volume":"44","author":"Rudkin","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib134","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/bjo.2009.176099","article-title":"Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications","volume":"94","author":"Russell","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib135","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.1995.13.7.1786","article-title":"High-dose intravenous melphalan: a review","volume":"13","author":"Samuels","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib136","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.1998.16.9.3000","article-title":"Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma","volume":"16","author":"Sandor","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib137","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ophtha.2007.10.039","article-title":"Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b","volume":"115","author":"Schechter","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib138","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003226-200201000-00003","article-title":"Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b","volume":"21","author":"Schechter","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib139","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2006.02.044","article-title":"Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma","volume":"142","author":"Schmack","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib140","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/1097-0142(20011201)92:11<2933::AID-CNCR10071>3.0.CO;2-G","article-title":"Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay","volume":"92","author":"Schouten-van Meeteren","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2013.01.003_bib141","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/09273940801899764","article-title":"Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma","volume":"16","author":"Sen","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2013.01.003_bib142","doi-asserted-by":"crossref","unstructured":"Sepulveda R, Pe'er J, Midena E, et\u00a0al. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmol. 94:532\u2013535","DOI":"10.1136\/bjo.2009.160820"},{"key":"10.1016\/j.survophthal.2013.01.003_bib143","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bjo.79.2.194","article-title":"Intravitreal chemotherapy for recurrent retinoblastoma in an only eye","volume":"79","author":"Seregard","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib144","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/bjophthalmol-2012-301528","article-title":"Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity","volume":"96","author":"Seregard","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib145","first-page":"406","article-title":"Thiotepa","volume":"12","author":"National Toxicology Program","year":"2011","journal-title":"Report on Carcinogens"},{"key":"10.1016\/j.survophthal.2013.01.003_bib146","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/sj.eye.6702327","article-title":"Phacoemulsification in patients with previous trabeculectomy: role of 5-fluorouracil","volume":"21","author":"Sharma","year":"2007","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2013.01.003_bib147","first-page":"471","article-title":"Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients","volume":"98","author":"Shields","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2013.01.003_bib148","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/archopht.123.1.109","article-title":"Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva","volume":"123","author":"Shields","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib149","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/bjo.86.2.244","article-title":"Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C","volume":"86","author":"Shields","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9394(02)01400-9","article-title":"Topical mitomycin C for extensive, recurrent conjunctival\u2013corneal squamous cell carcinoma","volume":"133","author":"Shields","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib151","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1442-9071.2010.02297.x","article-title":"Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey","volume":"38","author":"Shields","year":"2010","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib152","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.survophthal.2003.10.008","article-title":"Tumors of the conjunctiva and cornea","volume":"49","author":"Shields","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib153","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archopht.1997.01100150810025","article-title":"Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture","volume":"115","author":"Shields","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib154","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00417-007-0685-3","article-title":"Effects of intraocular irrigation with melphalan on rabbit retinas during vitrectomy","volume":"246","author":"Shimoda","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00003226-200201000-00004","article-title":"The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation","volume":"21","author":"Siganos","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib156","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archopht.120.8.1069","article-title":"Transscleral diffusion of carboplatin: an in vitro and in vivo study","volume":"120","author":"Simpson","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib157","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0161-6420(02)01125-9","article-title":"Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement","volume":"109","author":"Smith","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib158","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00003226-198903000-00010","article-title":"Lack of toxicity of a topical recombinant interferon alpha","volume":"8","author":"Smith","year":"1989","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib159","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bjophthalmol-2011-300829","article-title":"Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds","volume":"96","author":"Smith","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib160","doi-asserted-by":"crossref","first-page":"19068","DOI":"10.1074\/jbc.M109.040477","article-title":"Mitomycin C inhibits ribosomal RNA: a novel cytotoxic mechanism for bioreductive drugs","volume":"285","author":"Snodgrass","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.survophthal.2013.01.003_bib161","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10428199609054837","article-title":"A\u00a0single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases","volume":"23","author":"Soussain","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.survophthal.2013.01.003_bib162","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.ico.0000138834.42489.ba","article-title":"Ocular surface squamous neoplasia: a standard of care survey","volume":"24","author":"Stone","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib163","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ophtha.2008.01.006","article-title":"Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia","volume":"115","author":"Sturges","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib164","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1021\/bi971394i","article-title":"Mitomycin C\u2013DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C","volume":"36","author":"Suresh Kumar","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.survophthal.2013.01.003_bib165","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis","volume":"118","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib166","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1007\/s00894-012-1354-y","article-title":"Mechanisms and kinetics of thiotepa and tepa hydrolysis: DFT study","volume":"18","author":"Torabifard","year":"2012","journal-title":"J\u00a0Mol Model"},{"key":"10.1016\/j.survophthal.2013.01.003_bib167","series-title":"Education, and Welfare. Bioassay of Thio-TEPA for possible carcinogenicity","author":"U. S. Department of Health","year":"1978"},{"key":"10.1016\/j.survophthal.2013.01.003_bib168","first-page":"1230","article-title":"[Study on conservative treatment of retinoblastoma\u2014effect of intravitreal injection of melphalan on the rabbit retina]","volume":"99","author":"Ueda","year":"1995","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.survophthal.2013.01.003_bib169","first-page":"352","article-title":"[Conservative therapy for retinoblastoma\u2014effect of melphalan on in vitro electroretinogram]","volume":"98","author":"Ueda","year":"1994","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.survophthal.2013.01.003_bib170","doi-asserted-by":"crossref","first-page":"e27093","DOI":"10.1371\/journal.pone.0027093","article-title":"Nicotinamide inhibits\u00a0alkylating agent\u2013induced apoptotic neurodegeneration in the developing rat brain","volume":"6","author":"Ullah","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2013.01.003_bib171","first-page":"171","article-title":"Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma","volume":"5","author":"Vajzovic","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib172","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/S0004-27492009000200007","article-title":"[Safety and efficacy of intraoperative 5-fluorouracil infiltration in pterygium treatment]","volume":"72","author":"Valezi","year":"2009","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib173","first-page":"4720","article-title":"A\u00a0search for new metabolites of N, N', N'-triethylenethiophosphoramide","volume":"59","author":"van Maanen","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2013.01.003_bib174","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ophtha.2004.11.060","article-title":"Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma","volume":"112","author":"Van Quill","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib175","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bbmt.2012.01.021","article-title":"Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced\/inflammatory, and metastatic breast cancer","volume":"18","author":"VanderWalde","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.survophthal.2013.01.003_bib176","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0161-6420(99)90009-X","article-title":"Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia","volume":"106","author":"Vann","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib177","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bjo.83.11.1225","article-title":"New developments in sustained release drug delivery for the treatment of intraocular disease","volume":"83","author":"Velez","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib178","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archopht.119.10.1518","article-title":"Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma","volume":"119","author":"Velez","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib179","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001813-199010000-00002","article-title":"mechanism of action, usefulness and limitations","volume":"1","author":"Verweij","year":"1990","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.survophthal.2013.01.003_bib180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10637-005-4541-1","article-title":"From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates","volume":"24","author":"Walling","year":"2006","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.survophthal.2013.01.003_bib181","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s10384-005-0327-4","article-title":"An Asian patient with intraocular lymphoma treated by intravitreal methotrexate","volume":"50","author":"Wang","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib182","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/14656561003657145","article-title":"Intravesical therapy for bladder cancer","volume":"11","author":"Williams","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.survophthal.2013.01.003_bib183","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9394(14)70822-0","article-title":"Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia","volume":"124","author":"Wilson","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib184","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/jop.1999.15.401","article-title":"Toxic effects of mitomycin-C on cultured corneal keratocytes and endothelial cells","volume":"15","author":"Wu","year":"1999","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2013.01.003_bib185","first-page":"1705","article-title":"Mechanism of mitomycin-induced apoptosis in cultured corneal endothelial cells","volume":"14","author":"Wu","year":"2008","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2013.01.003_bib186","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0161-6420(01)00926-5","article-title":"Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C","volume":"109","author":"Yamamoto","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib187","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10147-004-0392-6","article-title":"The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma","volume":"9","author":"Yamane","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib188","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0161-6420(95)30866-4","article-title":"Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea","volume":"102","author":"Yeatts","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2013.01.003_bib189","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/ICO.0b013e3181a0a23d","article-title":"Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up","volume":"28","author":"Zaki","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2013.01.003_bib190","first-page":"71","article-title":"Retinal toxicity study of intravitreal carboplatin and iproplatin","volume":"20","author":"Zlioba","year":"1988","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.survophthal.2013.01.003_bib11a","unstructured":"Systemic vincristine, carboplatin, and etoposide, subtenon carboplatin, and local ophthalmic therapy in treating children with intraocular retinoblastoma. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00072384. Accessed March 9, 2013"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625713000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625713000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:39:57Z","timestamp":1758541197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625713000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":191,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0039625713000313"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2013.01.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local chemotherapeutic agents for the treatment of ocular malignancies","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2013.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}